Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
| 2023-01-09 Sale | 2023-01-11 8:29 pm | Jounce Therapeutics Inc. | JNCE | Cole Hugh M Chief Operating Officer | 16,634 | $1.111 | $18,481 | 110,082 (Direct) | View |
| 2022-01-07 Sale | 2022-01-11 8:55 pm | Jounce Therapeutics Inc. | JNCE | Cole Hugh M Chief Business Officer | 9,673 | $6.883 | $66,580 | 64,216 (Direct) | View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2025-06-11 Option Award | 2025-06-12 7:14 pm | N/A 2035-06-10 | Astria Therapeutics Inc. | ATXS | Cole Hugh M Director | 26,550 | $0 | 26,550 (Direct) | View |
| 2024-06-05 Option Award | 2024-06-06 4:05 pm | N/A 2034-06-04 | Astria Therapeutics Inc. | ATXS | Cole Hugh M Director | 14,100 | $0 | 14,100 (Direct) | View |
| 2023-06-02 Option Award | 2023-06-06 08:05 am | N/A 2033-06-01 | Astria Therapeutics Inc. | ATXS | Cole Hugh M Director | 14,100 | $0 | 14,100 (Direct) | View |
| 2022-08-01 Option Award | 2022-08-03 8:29 pm | N/A 2032-08-01 | Jounce Therapeutics Inc. | JNCE | Cole Hugh M Chief Operating Officer | 60,000 | $0 | 166,716 (Direct) | View |
| 2022-06-09 Option Award(A) | 2022-06-21 08:32 am | N/A 2032-06-08 | Astria Therapeutics Inc. | ATXS | Cole Hugh M Director | 8,333 | $0 | 8,333 (Direct) | View |
| 2022-06-09 Option Award | 2022-06-09 5:57 pm | N/A 2032-06-08 | Astria Therapeutics Inc. | ATXS | Cole Hugh M Director | 8,333 | $0 | 8,333 (Direct) | View |
| 2022-02-01 Option Award(A) | 2022-03-17 8:50 pm | N/A 2032-02-01 | Jounce Therapeutics Inc. | JNCE | Cole Hugh M Chief Business Officer | 85,000 | $0 | 85,000 (Direct) | View |
| 2022-02-01 Option Award | 2022-02-03 7:38 pm | N/A 2032-02-01 | Jounce Therapeutics Inc. | JNCE | Cole Hugh M Chief Business Officer | 127,500 | $0 | 191,716 (Direct) | View |
| 2021-06-02 Option Award | 2021-06-02 7:14 pm | N/A 2031-06-01 | CATABASIS PHARMACEUTICALS INC | CATB | Cole Hugh M Director | 100,000 | $0 | 100,000 (Direct) | View |